Table 2 How the IPV screening trial was cited (147 extractions from 112 sources)
Code/Sub-code | # sources given code (at least once) (% of 112) | # times code used for extraction (% of 147) |
|---|---|---|
1. Major finding (Harm/Benefit): Used when IPV screening trial major finding cited: | 61 (54.5) | 80 (54.4) |
1.1 No harm from screening | 13 (11.6) | 14 (9.5) |
1.2 No benefit to screening | 33 (29.5) | 35 (23.8) |
1.3 Both (no harm/no benefit) | 20 (17.9) | 20 (13.6) |
1.4 Benefit to screening | 8 (7.1) | 8 (5.4) |
1.5 Results inconclusive | 2 (1.8) | 2 (1.4) |
2. Methods/Measures/Statistics: Used when IPV screening trial method or measure cited: | 19 (17) | 21 (14.3) |
2.1 Women-centred outcomes | 2 (1.8) | 3 (2) |
2.2 Multi-level modelling | 1 (.9) | 1 (.7) |
2.3 Harms | 3 (2.7) | 3 (2) |
2.4 CAS cut-off | 2 (1.8) | 2 (1.4) |
2.5 WAST | 2 (1.8) | 3 (2) |
2.6 Other methods/measures/statistics | 9 (8) | 9 (6.1) |
3. General screening/IPV reference: Used to cite IPV screening trial for general point about screening or IPV: | 43 (38.4) | 51 (34.7) |
3.1 Screening debate | 15 (13.4) | 16 (10.9) |
3.2 Importance of IPV/screening discussion | 2 (1.8) | 2 (1.4) |
3.3 HCP education/training | 2 (1.8) | 2 (1.4) |
3.4 Other | 6 (5.4) | 7 (4.8) |
3.5 Insufficient evidence to support screening | 23 (20.5) | 24 (16.3) |
4. Interventions/Services: Used when IPV screening trial cited to show priority and/or research/knowledge gap in the area of interventions/services for IPV | 13 (11.6) | 14 (9.5) |
5. Minor findings: Used when a minor IPV screening trial finding cited: | 22 (19.6) | 31(21.1) |
5.1 Effect size | 1 (.9) | 1 (.7) |
5.2 Retention rate | 8 (7.1) | 8 (5.4) |
5.3 Women not talking to HCP | 8 (7.1) | 8 (5.4) |
5.3a Women talking to HCP | 4 (3.6) | 5 (3.4) |
5.4 Sensitivity | 2 (1.8) | 2 (1.4) |
5.5 Other minor finding | 7 (6.3) | 7 (4.8) |
6. No specific citation: Used when IPV screening trial listed as a reference or a source for readers to consult (but nothing specific cited in text) | 3 (2.7) | 3 (2) |
7. Incorrect: Used when IPV screening trial cited incorrectly (e.g., for a finding not actually reported) | 2 (1.8) | 3 (2) |
8. Other: Used when no other code appropriate, especially when reason for citing IPV screening trial is unclear | 2 (1.8) | 2 (1.4) |